Supplementary Methods, Figures 1 - 6 from Accumulation of Memory Precursor CD8 T Cells in Regressing Tumors following Combination Therapy with Vaccine and Anti-PD-1 Antibody
Lavakumar Karyampudi(Mayo Clinic), Keith L. Knutson(WinnMed), James Krempski(University of North Carolina at Chapel Hill), Barath Shreeder(Mayo Clinic), Purushottam Lamichhane(Mayo Clinic), Adam D. Scheid(Mayo Clinic), Marshall D. Behrens(Mayo Clinic), Kimberly R. Kalli(Mayo Clinic)
Cited by 0
Related Papers
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
|The Lancet Oncology|2013|434
Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
|JAMA Oncology|2017|409
Immune-Induced Epithelial to Mesenchymal Transition <i>In vivo</i> Generates Breast Cancer Stem Cells
|Cancer Research|2009|378
Tumor-Infiltrating Programmed Death Receptor-1+ Dendritic Cells Mediate Immune Suppression in Ovarian Cancer
|The Journal of Immunology|2011|250
Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19
|The Journal of Experimental Medicine|2021|232